Deferrals Flashcards
1
Q
Finasteride (eg Proscar, Procpecia)
A
1 month
2
Q
Isotretinoin (eg Absorica, Accutane, Amnesteem, Claravis, Myorisan, Sotret, Zenatane)
A
1 month
3
Q
Dutasteride (eg Avodart, Jaylyn)
A
6 months
4
Q
Acitretin (eg Soriatane)
A
3 years
5
Q
Etrtinate (eg Tegison)
A
Permanent
6
Q
Bovine insulin manufactured in the UK
A
Idefinite
7
Q
Aspirin, aspirin-containing medications, piroxicam (eg Feldene)
A
2 days
8
Q
Clopidogrel (eg Plavix), Ticlopidine (eg Ticlid), and Vorapaxar (eg Zontivity)
A
14 days
9
Q
Prasugrel (Effient) and ticagrelor (Brilinta)
A
7 days
10
Q
Warfarin (eg Coumadin, Warfilone, Jantoven)
A
7 days
11
Q
Heparin
A
7 days
12
Q
Direct thrombin inhibitors (eg Dabigatran)
A
2 days
13
Q
Direct Xa inhibitors (eg Rivaroxaban)
A
2 days
14
Q
Receipt of Hepatitis B Immune Globulin
A
12 months
15
Q
Family history of Creutzfeldt-Jakob disease (CJD)
A
Indefinite
16
Q
Pregnancy
A
6 weeks
17
Q
Receipt of allogeneic dura mater or pituitary growth hormone of human origin
A
Permanent
18
Q
Receipt of blood, components, or human tissue
A
12 months
19
Q
Receipt of any cells, tissues, or organs from a nonhuman animal source
A
Permanent
20
Q
Receipt of toxoids, or synthetic or killed viral, bacterial or rickettsial vaccines if donor is symptom-free and afebrile
A
none
21
Q
Anthrax vaccine
A
none
22
Q
Cholera vaccine
A
none
23
Q
Diphtheria vaccine
A
none
24
Q
Hep A vaccine
A
none
25
Hep B vaccine
none
26
Influenza vaccine
none
27
Lyme disease vaccine
none
28
Parathyphoid vaccine
none
29
Plague
none
30
Pertussis vaccine
none
31
Pneumococcal palysaccharide vaccine
none
32
Polio (Salk/injection) vaccine
none
33
Rabies vaccine
none
34
Rocky Mountain spotted fever vaccine
none
35
Tetanus vaccine
none
36
Typhoid (by injection) vaccine
none
37
recombinant vaccine
none
38
HPV vaccine (recombinant)
none
39
intranasal live attenuated flu vaccine
none
40
Measles (rubeola) vaccine
2 weeks
41
Mumps vaccine
2 weeks
42
Polio (Sabin/oral) vaccine
2 weeks
43
Thphoid (oral) vaccine
2 weeks
44
Yellow fever vaccine
2 weeks
45
German measles (rubella) vaccine
4 weeks
46
Chicken pox/shingles (varicella zoster) vaccine
4 weeks
47
Small pox vaccine without complications
until vaccination scab falls off, or 21 days, whichever is longer.
48
Small pox vaccine with complications
Deferral for 14 days after complete resolution of severe complications.
49
unlicensed vaccine
12 months
50
Confirmed positive for HBsAg
Permanent
51
Repeatedly reactive test for anti-HBc on more than one occasion
Indefinite
52
Positive HBV NAT result
Indefinite
53
Repeatedly reactive test for anti-HTLV
Indefinite
54
Present or past clinical or laboratory evidence of infection with HIV, HCV, HTLV, or T. cruzi
Indefinite
55
Babesiosis
Indefinite
56
Evidence or obvious stigmata of parenteral drug use
Indefinite
57
Use of a needle to administer nonprescription drugs
Indefinite
58
Mucous membrane exposure to blood
12 months
59
Nonsterile skin penetration with instruments or equipment contaminated with blood or body fluids other than the donor's own.
12 months
60
Tattoos or permanent make-up unless applied by a state-regulated entity with sterile needles and ink that has not been reused
12 months
61
Sexual contact or lived with individual who has acute or chronic Hep B
12 months
62
Sexual contact or lived with individual who has symptomatic Hep C
12 months
63
Sexual contact with an individual with HIV infection or at high risk of HIV infection
12 months
64
Incarceration in a correctional institution (including juvenile detention, lockup, jail, or prison) for more than 72 consecutive hours
12 months
65
Syphilis or gonorrhea
12 months (must have completed treatment)
66
West Nile Virus
120 days following diagnosis or onset of illness, whichever is later
67
Diagnosis of malaria
3 years after becoming asymptomatic
68
Individuals who have lived longer than 5 consecutive years in countries considered malaria-endemic
3 years after departure from malaria endemic - country
69
Individuals who have traveled to an area where malaria is endemic
12 months after departure from malaria endemic - country
70
Residence in the U.K. for 3 months or more, between 1980 and 1996
Indefinite
71
Military personnel (current and former), and their dependents, who spent time in military bases in northern Europe (1980-1990) for 6 months or more.
Indefinite
72
Military personnel (current and former), and their dependents, who spent time in military bases in southern Europe (1980-1996) for 6 months or more.
Indefinite
73
Donors who lived in France for 5 years or more, between 1980 and the present
Indefinite
74
Donors who received a transfusion in the U.K. between 1980 and the present
Indefinite
75
Blood donors who lived in Europe for 5 years or more, between 1980 and the present
Indefinite
76
Donor who has visited a malaria-endemic area, who is a prior resident of a malaria-endemic country (5 years), and who has been a resident of non-endemic countries for less than 3 consecutive years.
3 years
77
Donor who is a prior resident of a malaria-endemic country returns to malaria-endemic area after residence for 3 years consecutively in non-endemic countries
1 year
78
Hepatitis diagnosed after age 11
Indefinite
79
Double/triplet platelet apheresis
7 days
80
Clotting factor concentrates in hemophiliacs
Indefinite
81
Factors in nonhemophiliacs
1 year
82
Residents of non-endemic countries with travel to endemic area from >24hrs and less than 5 years
1 year
83
Residents of non-endemic countries with travel to endemic country but not endemic area for >24 hrs
none
84
Previous residents of endemic countries with travel to endemic area ( prior resident of endemic country
3 years (if asymptomatic)
85
Previous residents of endemic countries with travel to endemic area ( prior resident of endemic country >3 years after leaving)
1 year (if asymptomatic)
86
Non-routine dental work
72 hrs
87
Piroxicam (Feldene)
48 hrs
88
Frequent plasmapheresis donors need to have protein or SPEP performed every...
4 months
89
Frequent plasmapheresis donors must have blood loss less than _____/wk and less than ____/8 wks
25/200
90
Positive crossmatch with negative screen (3)
1. ABO incompatibilty
2. Antibodies to low incidence antigens
3. Positive donor DAT
91
+NAT, RR HBsAg/confirmed, NR Anti-HBc
Permanently deferred
92
+NAT, RR HBsAg/confirmed, RR Anti-HBc
Permanently deferred
93
+NAT, RR HBsAg/not confirmed, RR Anti-HBc
Permanently deferred
94
+NAT, NR HBsAg, RR Anti-HBc
Indefinitely deferred, may be eligible for re-entry in 8 wks
95
+NAT, NR HBsAg, NR Anti-HBc
Indefinitely deferred, may be eligible for re-entry in 8 wks
96
+NAT, RR HBsAg/not confirmed, NR Anti-HBc
Indefinitely deferred, may be eligible for re-entry in 8 wks
97
Anti-HCV window period
70-80 days
98
HCV NAT window period
7 days
99
Anti-HIV 1,2 window period
20 days
100
HIV-1 NAT window period
9-10 days
101
If anti-HIV 1,2 +, then must do
Anti-HIV-2
102
WNV deferral (3)
1. 28 days from symptom onset
2. 14 days after symptoms resolved
3. 120 days from positive test.
103
CMV infects which cells
monocytes
104
RR anti-HIV, +HIV NAT
permanent deferral
105
RR anti-HIV, WB neg/indeterm, + NR HIV NAT
indefinite deferral (my try re-entry in 8 weeks)
106
RR anti-HIV, +WB
permanent deferral
107
NR anti-HIV, +HIV NAT
indefinite deferral (my try re-entry in 8 weeks)
108
RR anti-HCV, + HCV NAT
permanent deferral
109
RR anti-HCV, + RR anti-HCV (different platform) OR +NAT
permanent deferral
110
NR anti-HCV, +HCV NAT
indefinite deferral (my try re-entry in 6 months)
111
RR anti-HBc x 1
No deferral
112
RR anti-HBc x 2
permanent deferral
113
RR anti-HBc, RR HBsAg
permanent deferral
114
RR HBsAg, confirmed neutralization
permanent deferral
115
RR HBsAg, nonconfirmed neutralization
retest in >8 weeks
116
+ HBV NAT, RR HBsAg/confirmed
permanent deferral
117
DTI and Xa inhibitors
1 week (2 days)
118
Interval between transfusion and measles/varicella vaccine: washed RBC
none
119
Interval between transfusion and measles/varicella vaccine: Adenine saline RBC
3 months
120
Interval between transfusion and measles/varicella vaccine: pRBC
6 months
121
Interval between transfusion and measles/varicella vaccine: whole blood
6 months
122
Interval between transfusion and measles/varicella vaccine: plasma/platelets
7 months
123
Cell saver storage temp and shelf life
RT - 4 hr
| 1-6C - 24 hr
124
Shed blood/post-salvage blood
6 hrs
125
Leishmaniasis
12 months after travel to Iraq
126
HBV vaccine
21 days
